Novo Holdings A/S - MENLO THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Novo Holdings A/S ownership history of MENLO THERAPEUTICS INC
ValueSharesWeighting
Q4 2018$5,229,000
-63.0%
1,269,145
-11.6%
0.74%
-34.5%
Q3 2018$14,148,000
+21.3%
1,436,3130.0%1.12%
-4.3%
Q2 2018$11,663,000
-77.2%
1,436,313
+5.5%
1.17%
-81.7%
Q1 2018$51,158,0001,361,3136.42%
Other shareholders
MENLO THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
DSC Advisors, L.P. 4,359,030$7,541,0008.27%
Healthcare Value Capital, LLC 1,700,000$2,941,0007.51%
683 Capital Management, LLC 5,550,208$9,602,0000.77%
Perceptive Advisors 22,876,410$39,576,0000.64%
Vivo Capital, LLC 3,643,824$6,304,0000.45%
Monashee Investment Management LLC 1,005,000$1,739,0000.26%
MYDA Advisors LLC 93,300$161,0000.10%
Sofinnova Investments, Inc. 725,571$1,256,0000.08%
CAAS CAPITAL MANAGEMENT LP 1,185,501$2,051,0000.07%
Grace Capital 36,012$62,0000.05%
View complete list of MENLO THERAPEUTICS INC shareholders